Amie T Joyce

Summary

Affiliation: Analytic and Consulting Services
Country: USA

Publications

  1. ncbi Effect of initial ziprasidone dose on length of therapy in schizophrenia
    Amie T Joyce
    PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    Schizophr Res 83:285-92. 2006
  2. doi Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA
    Amie T Joyce
    PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    J Rheumatol 36:743-52. 2009
  3. ncbi End-stage renal disease-associated managed care costs among patients with and without diabetes
    Amie T Joyce
    Senior Research Consultant, PharMetrics, Inc, 311 Arsenal St, Watertown, MA 02472, USA
    Diabetes Care 27:2829-35. 2004
  4. ncbi Impact of atypical antipsychotics on outcomes of care in schizophrenia
    Amie T Joyce
    PharMetrics Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    Am J Manag Care 11:S254-61. 2005
  5. pmc Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia
    Daniel A Ollendorf
    Analytic and Consulting Services, PharMetrics, Inc, Watertown, Massachusetts, USA
    MedGenMed 6:5. 2004
  6. ncbi Burden of illness among commercially insured patients with Alzheimer's disease
    Amie T Joyce
    PharMetrics Inc a unit of IMS, Watertown, MA, USA
    Alzheimers Dement 3:204-10. 2007
  7. ncbi Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study
    JoAnne M Foody
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02130, USA
    Curr Med Res Opin 24:1987-2000. 2008

Detail Information

Publications7

  1. ncbi Effect of initial ziprasidone dose on length of therapy in schizophrenia
    Amie T Joyce
    PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    Schizophr Res 83:285-92. 2006
    ..To examine the effects of initial ziprasidone dose on discontinuation rates, using retrospective integrated medical and pharmacy claims data...
  2. doi Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA
    Amie T Joyce
    PharMetrics, Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    J Rheumatol 36:743-52. 2009
    ....
  3. ncbi End-stage renal disease-associated managed care costs among patients with and without diabetes
    Amie T Joyce
    Senior Research Consultant, PharMetrics, Inc, 311 Arsenal St, Watertown, MA 02472, USA
    Diabetes Care 27:2829-35. 2004
    ..To examine the direct costs of care before and after onset of end-stage renal disease (ESRD) for patients with and without diabetes based on analyses of retrospective healthcare claims data...
  4. ncbi Impact of atypical antipsychotics on outcomes of care in schizophrenia
    Amie T Joyce
    PharMetrics Inc, 311 Arsenal Street, Watertown, MA 02472, USA
    Am J Manag Care 11:S254-61. 2005
    ..To compare persistence, compliance, and psychiatric treatment costs in patients who were initiated on atypical antipsychotics...
  5. pmc Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia
    Daniel A Ollendorf
    Analytic and Consulting Services, PharMetrics, Inc, Watertown, Massachusetts, USA
    MedGenMed 6:5. 2004
    ..Understanding the association between use of antipsychotics and onset of diabetes...
  6. ncbi Burden of illness among commercially insured patients with Alzheimer's disease
    Amie T Joyce
    PharMetrics Inc a unit of IMS, Watertown, MA, USA
    Alzheimers Dement 3:204-10. 2007
    ..CONCLUSIONS: The annual economic burden of AD to third-party payers is more substantial than previously estimated ($3,805 to $8,200)...
  7. ncbi Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study
    JoAnne M Foody
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02130, USA
    Curr Med Res Opin 24:1987-2000. 2008
    ..Therefore, we assessed patient persistence with atorvastatin and simvastatin in primary and secondary prevention patients enrolled in managed care...